Table 1 CSF white cell counts (WCC) and cytology results in MOG-IgG-positive EM
Units | Total | Attack | Remission | Acute MY subgroup | Acute ON subgroup | Acute BRAIN subgroup | |
|---|---|---|---|---|---|---|---|
CSF white cell counts | |||||||
Pleocytosis | Samples | 82/159 (51.6%) | 72/120 (60%) | 7/25 (28%) | 46/54 (85.2%) | 18/53 (34%) | 6/10 (60%) |
WCC, all samples | Cells/μl | 6 (0-463; 155) | 9 (0-463; 118) | 2.5 (0-37; 24) | 45.5 (1-463; 54) | 3 (0-135; 51) | 13.5 (0-68; 10) |
WCC, if elevated | Cells/μl | 31 (6-463; 80) | 40 (6-463; 71) | 21 (13-37; 7) | 60.15 (6-463; 46) | 9 (6-135; 17) | 16.5 (12-68; 6) |
WCC, > = 100 | Samples | 19/157 (12.1%) | 18/119 (15.1%) | 0/25 (0%) | 17/54 (31.5%) | 1/52 (1.9%) | 0/10 (0%) |
WCC, > = 100 | Cells/μl | 177 (108-463; 19) | 181.5 (108-463; 18) | n.a. (n.a.; 0) | 186 (108-463; 17) | 135 (135-135; 1) | n.a. (n.a.; 0) |
Lymphocytes | Samples | 77/77 (100%) | 58/58 (100%) | 14/14 (100%) | 30/30 (100%) | 24/24 (100%) | 4/4 (100%) |
Monocytes | Samples | 57/77 (74%) | 42/58 (72.4%) | 11/14 (78.6%) | 20/30 (66.7%) | 18/24 (75%) | 4/4 (100%) |
Neutrophils | Samples | 33/77 (42.9%) | 26/58 (44.8%) | 6/14 (42.9%) | 17/30 (56.7%) | 6/24 (25%) | 3/4 (75%) |
Eosinophils | Samples | 2/77 (2.6%) | 2/58 (3.4%) | 0/14 (0%) | 1/30 (3.3%) | 0/24 (0%) | 1/4 (25%) |
Basophils | Samples | 2/77 (2.6%) | 2/58 (3.4%) | 0/14 (0%) | 2/30 (6.7%) | 0/24 (0%) | 0/4 (0%) |
Plasma cells | Samples | 3/77 (3.9%) | 2/58 (3.4%) | 1/14 (7.1%) | 2/30 (6.7%) | 0/24 (0%) | 0/4 (0%) |
Lymphoid cells | Samples | 12/77 (15.6%) | 10/58 (17.2%) | 0/14 (0%) | 6/30 (20%) | 4/24 (16.7%) | 0/4 (0%) |
Macrophages | Samples | 6/77 (7.8%) | 3/58 (5.2%) | 2/14 (14.3%) | 0/30 (0%) | 2/24 (8.3%) | 1/4 (25%) |
No pleocytosis | Samples | 77/159 (48.4%) | 48/120 (40%) | 18/25 (72%) | 8/54 (14.8%) | 35/53 (66%) | 4/10 (40%) |